BACKGROUND Early detection of pulmonary hypertension (PH) in connective tissue disease (CTD) is crucial to ensuring
detection due to lack of evidence (3) . However, recent studies have described abnormal cardiac output (Q) responses for increments of mean pulmonary artery pressure (mPAP) as having the potential to assess the disease state and functional class (4) (5) (6) (7) . This concept can be applied to predict future development of overt PH. As noninvasive testing is preferable to invasive measurements for the purpose of screening, an easy and noninvasive measure of an individual's pulmonary circulation is required. Exercise and dobutamine stress echocardiography were widely used in the clinical setting, but some additional machines/drugs were also needed. In this study, we measured echocardiographic parameters post-6-min walk (6MW) as a classical technique for noninvasive stress testing. We hypothesized that pressure-flow relationships of the pulmonary circulation obtained by 6MW stress echocardiography would better delineate differential progression of PH in patients with CTD and predict the development of PH during follow-up.
METHODS STUDY POPULATION.
We designed a prospective study to assess the development of PH in patients with CTD. All patients had systemic sclerosis, systemic lupus erythematosus, or mixed connective tissue disease. Definitions of these diseases were according to the American College of Rheumatology diagnostic criteria (8) . Consecutive patients who underwent echocardiographic screening for PH and had a normal mPAP range (<25 mm Hg) at rest, as estimated by echocardiography, were recruited at our echocardiographic examination center between January 2010 and January 2013. Patients with moderate or severe valvular disease, atrial fibrillation/flutter, left ventricular ejection fraction <50%, significant shunts, significant interstitial lung disease (percent forced vital capacity <70%), or known coronary artery disease were excluded. Eighty-six patients with CTD underwent echocardiographic studies pre-and post-6MW. Four patients were excluded due to lack of a measurable tricuspid regurgitant jet, and 4 patients were excluded due to starting PH-specific therapy after the initial stress echocardiography. Therefore, 78 patients were included for final analysis. All patients underwent yearly echocardiographic follow-up studies for up to 5 years. The Institutional Review Board of the University of Tokushima approved the study protocol, and written informed consent was obtained from all subjects. were made in accordance with current guidelines (10) . RV fractional area change was defined using the formula: (end-diastolic area end À systolic area)/enddiastolic area Â 100. Systolic PAP was measured from the maximal continuous-wave Doppler velocity of the tricuspid regurgitant jet using the systolic transtricuspid pressure gradient calculated by the modified Bernoulli equation. Right atrial pressure was estimated from the inferior vena cava diameter and collapsibility (11) . The mean PAP was calculated as:
6MW STRESS ECHOCARDIOGRAPHY. The 6MW test was performed indoors along a flat, straight, enclosed corridor with a hard surface (13) . The walking course was 50 m in length. The transcutaneous arterial oxygen saturation was determined by pulse oximetry.
The peak tricuspid regurgitation jet was obtained by echocardiography post-6MW (within 10 s). Q was obtained from electric cardiometry (Aesculon Electrical Velocimetry, Osypka Medical GmbH, Berlin, Germany) at the same time (14) . In the previous study, the agreement between Q by electric cardiometry and by pulmonary artery catheter was clinically acceptable (15) . In our cohort with invasive data (n ¼ 16), there is a good correlation between right heart cath- 
RESULTS
PATIENT CHARACTERISTICS. Baseline characteristics of the study group are presented in Table 1 .
Systemic sclerosis was the most common underlying CTD (70%), followed by systemic lupus erythematosus (20%) and mixed connective tissue disease (10%). Blood pressure and heart rate at baseline were well-controlled in this cohort (heart rate: 73 AE 12 beats/min and systolic blood pressure: 126 AE 20 mm Hg). Post-6MW, heart rate, blood pressure, output, and mPAP were increased. Echocardiographic variables are shown in Table 2 . The average DmPAP/DQ was 3.4 AE 4.4 mm Hg/l/min. The intraobserver variability for the measurement of DmPAP/ DQ was 5.6% AE 3.8%; interobserver variability was 7.2% AE 5.1%. DmPAP/DQ, mm Hg/l/min (p < 0.001) ( Figure 2C ). The Central Illustration shows multipoint mPAP and Q plots at baseline and post 6MW. The DmPAP/DQ in patients with events (development of PH) was significantly higher than in patients without events (6.1 AE 3.8 mm Hg/l/min vs. 2.6 AE 4.3 mm Hg/l/min; p < 0.001). Using a receiver-operating characteristic curve, we found that the best cutoff value of DmPAP/DQ for predicting the development of pulmonary hypertension was >3.3 mm Hg/l/min.
PREDICTING TIME TO PH DEVELOPMENT. Hazards ratios of the relevant parameters are shown in 
CONCLUSIONS
We have demonstrated that DmPAP/DQ using 6MW stress echocardiography as a marker of functional state of the pulmonary circulation is a good predictor of PH development in CTD. This technique is potentially more practical than other stress 
